For the Inventor, By the Inventor

Enter assignee name

Dna Vec Research Inc.

USPTO Granted Patents = 31

CIPO Patents = 10

EPO Patents = 6

Forward Citations = 144

Loading Chart...

Loading Chart...

75 inventors (with patents filed for the assignee):

Mamoru Hasegawa (27 out of 37 patents)

Yoshiyuki Nagai (8 out of 8 patents)

Tsuneaki Sakata (7 out of 9 patents)

4. Atsushi Kato (6 out of 63 patents)

5. Akihiro Iida (6 out of 8 patents)

6. Makoto Inoue (6 out of 10 patents)

7. Yasuji Ueda (5 out of 8 patents)

8. Tatsuo Shioda (5 out of 5 patents)

9. Yoshikazu Yonemitsu (4 out of 15 patents)

10. Fukashi Murai (4 out of 4 patents)

11. Makoto Asakawa (4 out of 4 patents)

12. Teruo Akuta (4 out of 5 patents)

13. Mahito Nakanishi (4 out of 5 patents)

14. Katsuo Takeda (4 out of 4 patents)

15. Masanori Kobayashi (3 out of 68 patents)

31 patents: Sort by Forward Citations

1. 8889118 - Anticancer agent containing dendritic cell having RNA virus transferred thereinto (2014-11-18),

2. 8741650 - Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter (2014-06-03),

3. 8217019 - AIDS virus vaccines using Sendai virus vector (2012-07-10),

4. 8211868 - Paramyxovirus vector encoding angiogenesis gene and use thereof (2012-07-03),

5. 7709621 - Vectors with modified protease-dependent tropism (2010-05-04),

6. 7521043 - Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines (2009-04-21),

7. 7510706 - Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity (2009-03-31),

8. 7442544 - Recombinant sendai virus (2008-10-28),

9. 7402427 - Vectors with modified protease-dependent tropism (2008-07-22),

10. 7323337 - Gene transfer into primate embryonic stem cells using VSV-G pseudotyped simian immunodeficiency virus vectors (2008-01-29),

11. 7314614 - Recombinant sendai virus vector for introducing exogenous genes to airway epithelia (2008-01-01),

12. 7241617 - Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci (2007-07-10),

13. 7226786 - Envelope gene-deficient Paramyxovirus vector (2007-06-05),

14. 7144579 - Paramyxoviruses comprising modified transcription start sequence (2006-12-05),

15. 7101685 - Recombinant Sendai virus (2006-09-05),

DNA VEC Research Inc. is a leading biotechnology company specializing in DNA sequencing and gene editing technologies. With a team of top scientists and cutting-edge laboratory facilities, we are dedicated to advancing genetic research and innovation. Our expertise lies in developing high-precision, cost-effective genomic analysis solutions, enabling researchers and clinicians worldwide to gain valuable insights into the complex nature of DNA. Visit our website to learn more about our services and products.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

31 Patents

#10 in Ibaraki

#2,217 in Japan

#20,604 in the World

Dna Vec Research Inc.

Forward Citations = 144

75 inventors:

Mamoru Hasegawa (27 out of 37 patents)

Yoshiyuki Nagai (8 out of 8 patents)

Tsuneaki Sakata (7 out of 9 patents)

4. Atsushi Kato (6 out of 63 patents)

5. Akihiro Iida (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…